日韩精品久久无码中文字幕,青青草视频下载,一区二区在线观看电影院,一色屋精品视频在线观看

加入收藏 | 設(shè)為首頁 | 聯(lián)系我們

產(chǎn)品搜索

產(chǎn)品分類

聯(lián)系我們

聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com

產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73190BCR-ABL1 T315I/BaF3

BCR-ABL1 T315I/BaF3
名稱 BCR-ABL1 T315I/BaF3
型號 CBP73190
報價
特點 BCR-ABL1 [T315I]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO;
  • 詳細(xì)內(nèi)容
CBP73190
I. Introduction

Cell Line Name:

BCR-ABL1 [T315I]/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

 
II.Background

Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes.
ABL1 is a tyrosine kinase, and, in normal cells, it plays a role in cellular differentiation and regulation of the cell cycle. The BCR-ABL1 fusion gene creates a constitutively active tyrosine kinase, which leads to uncontrolled proliferation.
Imatinib is the first-generation ABL tyrosine kinase inhibitor, and it was approved by the FDA in 2001; label indications for CML include use in newly diagnosed adult and pediatric patients and in patients after failure of interferon-alpha therapy. While treatment responses to imatinib are often dramatic and lasting, 30–40% of patients will eventually need further treatment (Santos et al. 2011). In many but not all cases, this is due to the acquisition of point mutations in the tyrosine kinase domain of the BCR-ABL1 fusion gene, which renders the protein insensitive to the inhibitory effect of imatinib. This type of disease progression led to the development of second-line TKIs: dasatinib, nilotinib, and bosutinib. Dasatinib and bosutinib have the additional advantage of being inhibitors of SRC.
The second-generation TKIs, dasatinib, nilotinib, and bosutinib, are more potent than imatinib, and they were developed to treat cases of CML resistant to imatinib. Dasatinib and nilotinib are approved for use in CML in newly diagnosed adults, while dasatinib, nilotinib, and bosutinib are approved for use in adults with resistance or intolerance to prior therapy that included imatinib (FDA 2012). Soverini et al. (2011) made mutation-specific treatment decision recommendations that were adopted by NCCN (2012). Recommendations based on preclinical data are as follows: for T315I, HSCT or clinical trial; for V299L, T315A, and F317L/V/I/C, consider nilotinib rather than dasatinib; for Y253H, E255K/V, and F359V/C/I, consider dasatinib rather than nilotinib; and for all other mutations, consider high-dose imatinib, dasatinib, or nilotinib.
Ponatinib is a third-line TKI, developed specifically to address imatinib resistance due to the BCR-ABL1 T315I resistance mutation. Ponatinib is currently being investigated in phase III clinical trials.

 
III. Representative Data

1. WB of BCR-ABL1 [T315I]/BaF3


2. Sanger of BCR-ABL1 [T315I]/BaF3


Figure 2. BCR-ABL1 T315I/BaF3 T315I

Figure 3. BCR-ABL1 T315I/BaF3 Fusion

 

3. Anti-proliferation assay

Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 T315I Cells.

如果你對CBP73190BCR-ABL1 T315I/BaF3感興趣,想了解更詳細(xì)的產(chǎn)品信息,填寫下表直接與廠家聯(lián)系:


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7

化工儀器網(wǎng)

推薦收藏該企業(yè)網(wǎng)站
天天日狼人伊人| 欧美日韩综合| 成人在线午夜你懂的视频| 操操影院免费看| 欧美激情性a片在线观看| 国产 欧美 日产 手机| 久久久噜噜噜久久久久久久| 国产精品69XXXXX| 亚洲熟伦熟女新五十熟妇| 中文字幕亚洲高清在线二区| 丁香婷婷激情五月在线观看| 国产黄色强势奸| 蜜臀精品欧美一区二区三区| 女人玩男人机机免费视频| 亚洲天堂中文字幕婷婷婷| 97精产国品一二三产区| JJ插逼逼高潮呻吟视频| 亚洲精品乱码久久久久久无| 国产精品一区二区av交换| 亚洲大片免费看| 伊人免费在线观看高清版| 亚洲精品久久久蜜臀av| 2023久久国产小视频| 第九色成人Av| 浪潮国产亚洲精品一二区| 一区二区免费看| 国产迷亚洲一区二区三区| 亚洲欧美狂白浆一区二区| 半甜欲水1V6| 女朋友的妈妈电影完整版| 一女被多男玩弄在线播放| 国产精品一区一区三区区别| 狠狠爱五月丁香亚洲综合| 仓井空一区二区免费视频| 成人 在线 免费 视频| 全部费免一级毛片不收费| 日韩人妻少妇一区二区三区| 精品亚洲欧美一区二区在线| 久久本道综合色狠狠五月| 成人黄色av免费在线观看| 敌伦交换第11部分小说|